Kamran A.

Kamran A. started their work experience in 2009 as a Research Associate at the University of California, San Francisco. Kamran then moved on to become a Graduate Student Researcher at UC Irvine in 2010, where they worked on research in Mammalian Synthetic Biology and Directed Evolution. During this time, they were also an NSF iGERT Fellow and focused on projects such as optical control of stem cell differentiation and directed evolution of photoactivatable proteins and light emitting luciferases.

In 2017, Kamran joined Notable as a Senior Scientist, and later became the Head of Platform and Discovery in 2019. Their role at Notable involved leading the platform and discovery efforts in the company.

Kamran's most recent work experience is as the CTO and Co-founder of Eigen Therapeutics, a position they have held since 2022.

Kamran A. completed their undergraduate education at the University of California, Berkeley from 2005 to 2009. They earned a Bachelor of Arts degree with a major in Molecular Cell Biology during this time. Following their bachelor's degree, Kamran A. pursued further education at UC Irvine, where they enrolled as a PhD Candidate in Biomedical Engineering starting in 2010. They continued their studies at UC Irvine until 2017.